Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.5 | 40.0 | 0.0 | 0.0 |
| Revenue growth | -98.9% | | | |
| Cost of goods sold | 0.3 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.1 | 40.0 | 0.0 | 0.0 |
| Gross margin | 24.5% | 100.0% | | |
| Research and development | 49.3 | 79.4 | 44.5 | 42.4 |
| General and administrative | 26.6 | 33.9 | 29.8 | 10.0 |
| EBIT | -75.8 | -73.3 | -73.2 | -54.5 |
| EBIT margin | -16539.3% | -183.3% | | |
| Pre-tax income | -68.4 | -55.6 | -65.0 | -40.5 |
| Income taxes | 0.3 | 0.0 | 0.1 | 0.1 |
| Tax rate | | 0.0% | | |
| Net income | -68.7 | -55.6 | -65.1 | -40.6 |
| Net margin | -15000.2% | -138.9% | | |
| |
| Diluted EPS | ($0.13) | ($0.12) | ($0.25) | ($0.39) |
| Shares outstanding (diluted) | 529.1 | 473.2 | 262.9 | 105.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|